Moderna Inc. buy UBS Group AG
Start price
21.11.25
/
50%
€20.58
Target price
21.11.26
-
Performance (%)
454.52%
Price
22:25
€114.12
Summary
This prediction is currently active. With a performance of 454.52% the BUY prediction by UBS_Group_AG is a big success. This prediction currently runs until 21.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 171.149% | 171.149% |
| iShares Core DAX® | -1,06 % | 5,01 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % |
| iShares S&P 500 | -1,78 % | 1,39 % |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for MRNA provided by MarketBeat